Dominic Culligan
- Hematology top 1%
- Pathology and Forensic Medicine top 1%
- Oncology top 5%
- Immunology top 5%
- Genetics top 2%
- Co-authors
- Mark A. VickersRobert N. BarkerNeil A. MarshallPeter JohnstonYen‐Lin CheeLaura MunroHenry G. WatsonLinsey Christie
- Topics
- Acute Myeloid Leukemia Research (38 papers)Lymphoma Diagnosis and Treatment (24 papers)Acute Lymphoblastic Leukemia research (10 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
Dominic Culligan
74 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Hematology 1.0k
- Pathology and Forensic Medicine 929
- Oncology 767
- Immunology 586
- Genetics 504
Countries citing papers authored by Dominic Culligan
This map shows the geographic impact of Dominic Culligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominic Culligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominic Culligan more than expected).
Fields of papers citing papers by Dominic Culligan
This network shows the impact of papers produced by Dominic Culligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominic Culligan. The network helps show where Dominic Culligan may publish in the future.
Co-authorship network of co-authors of Dominic Culligan
This figure shows the co-authorship network connecting the top 25 collaborators of Dominic Culligan. A scholar is included among the top collaborators of Dominic Culligan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominic Culligan. Dominic Culligan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 7 | |
| 3 | Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphomabreakdown → | 407 |
| 4 | 60 | |
| 5 | 8 | |
| 6 | 58 | |
| 7 | 109 | |
| 8 | 5 | |
| 9 | 42 | |
| 10 | 3 | |
| 11 | 7 | |
| 12 | 104 | |
| 13 | 52 | |
| 14 | 37 | |
| 15 | 54 | |
| 16 | Rexinoid therapy bypasses the differentiation block associated with acute promyelocytic leukemia harboring the PLZF/RAR alpha rearrangement. | 3 |
| 17 | 26 | |
| 18 | 169 | |
| 19 | 1 | |
| 20 | 12 |
About Dominic Culligan
Dominic Culligan is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 75 papers that have together received 2.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (38 papers), Lymphoma Diagnosis and Treatment (24 papers) and Acute Lymphoblastic Leukemia research (10 papers). The work is most often cited by research in Hematology (1.0k citations), Pathology and Forensic Medicine (929 citations) and Genetics (504 citations). Dominic Culligan has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Mark A. Vickers, Robert N. Barker, Neil A. Marshall, Peter Johnston, Yen‐Lin Chee, Laura Munro, Henry G. Watson, Linsey Christie, David Bowen and Sally F. Barrington. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.